Skip to main content

5 Result(s)

within Feng-Tao Liu Remove this filter Medicine & Public Health Remove this filter Neuroradiology Remove this filter

and

  1. No Access

    Article

    Clinical features, disease progression, and nuclear imaging in ATXN2-related parkinsonism in a longitudinal cohort

    Spinocerebellar ataxia 2 (SCA2) with a low range of CAG repeat expansion of ATXN2 gene can present with predominant or isolated parkinsonism that closely resembles Parkinson’s disease (PD). This study is aimed at...

    Yi-Dan Xu, **n-Yue Zhou, Si-Di Wei, Feng-Tao Liu, Jue Zhao… in Neurological Sciences (2024)

  2. No Access

    Article

    Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson’s disease

    Our aim is to investigate the associations of sleep disorders with cerebrospinal fluid (CSF) α-synuclein (α-syn) in healthy controls (HCs), and patients with prodromal and early Parkinson’s disease (PD).

    **ao-Tong Wang, Huan Yu, Feng-Tao Liu, Can Zhang, Ya-Hui Ma… in Journal of Neurology (2022)

  3. No Access

    Article

    Predictors of cognitive impairment in Parkinson’s disease: a systematic review and meta-analysis of prospective cohort studies

    Cognitive impairment is a debilitating manifestation in Parkinson’s disease (PD). We sought to investigate predictors of PD-CI (PD with cognitive impairment).

    Yu Guo, Feng-Tao Liu, **ao-He Hou, Jie-Qiong Li, **-Peng Cao… in Journal of Neurology (2021)

  4. No Access

    Article

    Diagnosis and surgical treatment of non-lesional temporal lobe epilepsy with unilateral amygdala enlargement

    Exploring the role of amygdala enlargement (AE) in temporal lobe epilepsy (TLE) without ipsilateral mesial temporal sclerosis (MTS) using comprehensive presurgical workup tools including traditional tools, aut...

    Zhen Fan, Bing Sun, Li-qin Lang, Jie Hu, N. U. Farrukh Hameed… in Neurological Sciences (2021)

  5. No Access

    Article

    Considerations before initiating therapy in Parkinsonism: basing on the quality of life

    Improvement of quality-of-life (QoL) has been termed as a primary objective in initiating therapy in both Parkinson’s disease (PD) and multiple system atrophy Parkinsonian subtype (MSA-P). We aimed to compare ...

    Shu-** He, Zhen-Yang Liu, Yu-Jie Yang, Cong Shen, Yu-Jie Du… in Journal of Neurology (2019)